The storage of animal manure is a major source of gaseous emissions. The aim of this study was to evaluate the effects of biochar and clinoptilolite on the composition and gaseous emissions during the storage of separated liquid fraction of pig slurry. The experiment was carried out using containers with 6 L of pig slurry each. The additives biochar and clinoptilolite were added alone and mixed to the pig slurry at a rate of 2.5% each, in a total of four treatments with three replicates including the control. Gaseous emissions were monitored by a photoacoustic multigas monitor, and slurry samples were collected at 0 and 85 days and their composition assessed. Results showed that the addition of biochar could modify the physicochemical properties of the slurry. The addition of biochar did not reduce the E. coli during the experiment while clinoptilolite decreased its prevalence. The addition of biochar or clinoptilolite reduced significantly the NH3 emission during the storage of slurry, but no advantages were gained with their combination. The addition of biochar significantly reduced the CO2 and CH4 emissions relative to clinoptilolite, however N2O emissions and global warming potential did not differ among the additives. We conclude that the biochar and clinoptilolite are recommended as a mitigation measure to reduce gaseous emissions and preserve the fertiliser value at slurry storage.
Background
Hyaluronic acid (HA) injectable gels are used to define, enhance, and volumize facial regions, such as the lips, a common treatment area.
Objective
Evaluate the effectiveness and safety of the HA injectable gel Juvéderm Volift (Allergan, Irvine, CA) with Lidocaine (VYC-17.5L) for lip augmentation in real-world clinical practice.
Methods
This prospective, open-label, multicenter study initially designed for 6 months, then extended to 12 months, enrolled adults with an overall grade of minimal to moderate on the Lip Fullness Scale 2 (LFS2). Optional touch-up and repeat treatments occurred at day 14 and month 12, respectively. The primary endpoint was a ≥1-point improvement on the LFS2 at day 30. Other endpoints included improvements on the FACE-Q Satisfaction with Lips questionnaire, Global Aesthetic Improvement Scale (GAIS), subject assessment of natural look/feel of lips, and investigator assessment of dynamic lip lines upon animation. Injection site reactions (ISRs) and adverse events (AEs) were recorded.
Results
Of 60 subjects enrolled (mean age, 36.8 years; 98.3% female), 59 were evaluable for efficacy at day 30; 13 (21.4%) received touch-up treatment. Thirty-six of 40 subjects completed the extension study (month 12). LFS2 responder rates were 93.2% at day 30 (primary endpoint) and 39.0% at month 12. Mean scores on the FACE-Q questionnaire improved from baseline by 45.2 points and 23.6 points at day 30 and month 12, respectively. Most subjects showed improvements on the GAIS. The majority of ISRs were mild/moderate; no serious AEs occurred.
Conclusions
VYC-17.5L was effective and well tolerated for lip augmentation through 12 months posttreatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.